Open AccessINFLUENCE OF DELIVERY ON PATIENTS’ ADHERENCE TO THERAPY OF BRONCHOOBSTRACTIVE DISEASES
Author(s) -
N V Shartanova
Publication year - 2014
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja515
Subject(s) - medicine , dry powder inhaler , inhaler , inhalation , dosing , asthma , drug delivery , intensive care medicine , drug , disease , quality of life (healthcare) , pharmacology , anesthesia , nursing , chemistry , organic chemistry
Bronchial asthma (BA) - a global public health problem worldwide. All treatments aimed at improving the control of symptoms of the disease, prevention of exacerbations and improving the quality of life for patients. The use of inhalation therapy is the basis for the treatment of all bronchoobstructive diseases. The effectiveness of treatment depends not only on the quality of the inhaled drug, but also by means of delivery of the drug into the bronchi. Easyhaler - a new dry powder inhaler, inhalation activated enables precise dosing of the drug. According to various studies, the method of delivery of drugs has proven high efficiency, ease to use and adherence of patients to the unit.